Colgate-Palmolive Company

Celsius delivers explosive revenue growth by capturing a large share of the functional beverage market. Colgate-Palmolive provides defensive stability with a massive global footprint and a focus on everyday household essentials.

I rank all 69 S&P 500 Dividend Aristocrats by my 9F Quality Scores, segmenting them into undervalued, fairly valued, and overvalued groups. My consensus fair value estimates, blending up to 40 data points per stock, highlight 12 undervalued and 18 fairly valued Aristocrats, with 39 currently overvalued. Investment candidates vary by style: ADP, BRO, and NDSN for growth; NEE for total return; PEP and O for income; CAT and GWW for past performance.

Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Colgate-Palmolive Company remains a long-term portfolio anchor. CL is fundamentally back at volume growth, has a record-high 61.5% gross margins, and benefits from emerging markets. CL stock excels as a volatility hedge amid market turbulence, serving a portfolio tactical function. Valuation is elevated: adjusted P/E at 26x versus the 10-year average of 24x, and dividend yield below long-term norms, reducing margin of safety.

Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Clorox's nearly 6% yield towers over Colgate's modest payout, making it look like a retiree's dream income stock.

Soda, toothpaste, phone service, electricity, and prescription drugs all share one trait: people keep buying them when the economy turns ugly.

Six dividend stocks, one portfolio, two very different tax outcomes depending on where you hold them. The account you choose today quietly determines how much of every future payout you actually get to keep.